TY  - JOUR 
AU  - Calvo Martínez, Lourdes
PY  - 2014
SN  - 0007-0920
UR  - http://hdl.handle.net/20.500.11940/7866
LA  - eng
TI  - Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial
DO  - 10.1038/bjc.2013.831
T2  - BRITISH JOURNAL OF CANCER
M2  - 1139
VL  - 110
ER  -